BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 24833101)

  • 21. Prognostic impact of the cancer stem cell related markers ALDH1 and EZH2 in triple negative and basal-like breast cancers.
    De Brot M; Rocha RM; Soares FA; Gobbi H
    Pathology; 2012 Jun; 44(4):303-12. PubMed ID: 22544210
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of cancer stem cell markers is prognostic in metastatic gastroesophageal adenocarcinoma.
    Brungs D; Lochhead A; Iyer A; Illemann M; Colligan P; Hirst NG; Splitt A; Liauw W; Vine KL; Pathmanandavel S; Carolan M; Becker TM; Aghmesheh M; Ranson M
    Pathology; 2019 Aug; 51(5):474-480. PubMed ID: 31230819
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclooxygenase isoenzyme-2 and vascular endothelial growth factor are associated with poor prognosis in esophageal adenocarcinoma.
    Prins MJ; Verhage RJ; ten Kate FJ; van Hillegersberg R
    J Gastrointest Surg; 2012 May; 16(5):956-66. PubMed ID: 22258871
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic evaluation of Nanog, Oct4, Sox2, PCNA, Ki67 and E-cadherin expression in gastric cancer.
    Li N; Deng W; Ma J; Wei B; Guo K; Shen W; Zhang Y; Luo S
    Med Oncol; 2015 Jan; 32(1):433. PubMed ID: 25491144
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Loss of ARID1A expression is associated with DNA mismatch repair protein deficiency and favorable prognosis in advanced stage surgically resected esophageal adenocarcinoma.
    Lowenthal BM; Nason KS; Pennathur A; Luketich JD; Pai RK; Davison JM; Ma C
    Hum Pathol; 2019 Dec; 94():1-10. PubMed ID: 31655170
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic relevance of NG2/CSPG4, CD44 and Ki-67 in patients with glioblastoma.
    Tsidulko AY; Kazanskaya GM; Kostromskaya DV; Aidagulova SV; Kiselev RS; Volkov AM; Kobozev VV; Gaitan AS; Krivoshapkin AL; Grigorieva EV
    Tumour Biol; 2017 Sep; 39(9):1010428317724282. PubMed ID: 28945172
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of cancer stem cell markers ALDH1, BCL11B, BMI-1, and CD44 in the prognosis of advanced HNSCC.
    Jakob M; Sharaf K; Schirmer M; Leu M; Küffer S; Bertlich M; Ihler F; Haubner F; Canis M; Kitz J
    Strahlenther Onkol; 2021 Mar; 197(3):231-245. PubMed ID: 32588101
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of SRY-box2 (SOX2) expression and its impact on survival of patients with oesophageal adenocarcinoma.
    Ten Kate FJC; van Olphen SH; Bruno MJ; Wijnhoven BPL; van Lanschot JJB; Looijenga LHJ; Fitzgerald RC; Biermann K
    Br J Surg; 2017 Sep; 104(10):1327-1337. PubMed ID: 28692180
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cancer stem cell marker ALDH1 expression is associated with lymph node metastasis and poor survival in esophageal squamous cell carcinoma: a study from high incidence area of northern China.
    Wang Y; Zhe H; Gao P; Zhang N; Li G; Qin J
    Dis Esophagus; 2012 Aug; 25(6):560-5. PubMed ID: 22098156
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical implications of CD44+/CD24- tumor cell ratio in breast cancer.
    Liu C; Luo Y; Liu X; Lu P; Zhao Z
    Cancer Biother Radiopharm; 2012 Jun; 27(5):324-8. PubMed ID: 22702496
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of musashi-1 and ALDH1 as carcinogenesis, progression, and poor-prognosis related biomarkers for gallbladder adenocarcinoma.
    Liu DC; Yang ZL; Jiang S
    Cancer Biomark; 2010-2011; 8(3):113-21. PubMed ID: 22012766
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinicopathological significance of cancer stem cell markers CD44 and ALDH1 expression in breast cancer.
    Louhichi T; Ziadi S; Saad H; Dhiab MB; Mestiri S; Trimeche M
    Breast Cancer; 2018 Nov; 25(6):698-705. PubMed ID: 29845398
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aberrant expression of cancer stem cell markers (CD44, CD90, and CD133) contributes to disease progression and reduced survival in hepatoblastoma patients: 4-year survival data.
    Bahnassy AA; Fawzy M; El-Wakil M; Zekri AR; Abdel-Sayed A; Sheta M
    Transl Res; 2015 Mar; 165(3):396-406. PubMed ID: 25168019
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic Significance of CD44v6, CD133, CD166, and ALDH1 Expression in Small Intestinal Adenocarcinoma.
    Eom DW; Hong SM; Kim G; Bae YK; Jang KT; Yu E
    Appl Immunohistochem Mol Morphol; 2015; 23(10):682-8. PubMed ID: 25710579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation between epidermal growth factor receptor and tumor stem cell markers CD44/CD24 and their relationship with prognosis in breast invasive ductal carcinoma.
    Zheng Z; Shao N; Weng H; Li W; Zhang J; Zhang L; Yang L; Ye S
    Med Oncol; 2015 Jan; 32(1):275. PubMed ID: 25429827
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Prognostic Value of Cancer Stem Cell Markers in Cervical Cancer: A Systematic Review and Meta-Analysis.
    Fahmi MN; Hertapanndika IN; Kusuma F
    Asian Pac J Cancer Prev; 2021 Dec; 22(12):4057-4065. PubMed ID: 34967589
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neoadjuvant treatment response in negative nodes is an important prognosticator after esophagectomy.
    Nieman DR; Peyre CG; Watson TJ; Cao W; Lunt MD; Lada MJ; Han MS; Jones CE; Peters JH
    Ann Thorac Surg; 2015 Jan; 99(1):277-83. PubMed ID: 25442991
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
    Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
    World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cancer stem cells markers CD44, CD24 and ALDH1 in breast cancer special histological types.
    de Beça FF; Caetano P; Gerhard R; Alvarenga CA; Gomes M; Paredes J; Schmitt F
    J Clin Pathol; 2013 Mar; 66(3):187-91. PubMed ID: 23112116
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gene expression profiles in esophageal adenocarcinoma predict survival after resection.
    Pennathur A; Xi L; Litle VR; Gooding WE; Krasinskas A; Landreneau RJ; Godfrey TE; Luketich JD
    J Thorac Cardiovasc Surg; 2013 Feb; 145(2):505-12; discussion 512-3. PubMed ID: 23321130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.